Unfamiliar territory of a familiar drug: INH-induced erythroderma
Eurasian Journal of Pulmonology · 2022
DOI: 10.14744/ejp.2021.8321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Pulmonology, 2022. Verfasst von Roopa Kancherla.
Abstract (Originalsprache)
Tuberculosis is a major cause of ill health, and one of the top ten causes of death worldwide. Treatment with multiple first-line drugs is the standard recommended treatment for drug-sensitive tuberculosis. Isoniazid (INH) is an important component of first-line therapy. Erythroderma is a rare but serious adverse drug reaction. We report here a case of a 64-year-old man who presented with generalized itchy, red-colored scaly lesions associated with extensive skin peeling after 8 weeks of antitubercular treatment (ATT). After the withdrawal of ATT, skin lesions improved along with symptomatic treatment. On sequential rechallenge with INH, the patient developed a recurrence of skin lesions, which confirmed the diagnosis of INH-induced erythroderma.
Zitieren
APA
Kancherla, R. (2022). Unfamiliar territory of a familiar drug: INH-induced erythroderma. Eurasian Journal of Pulmonology. https://doi.org/10.14744/ejp.2021.8321
Vancouver
Kancherla R. Unfamiliar territory of a familiar drug: INH-induced erythroderma. Eurasian Journal of Pulmonology. 2022. doi:10.14744/ejp.2021.8321
BibTeX
@article{Kancherla2022,
author = {Kancherla, Roopa},
title = {Unfamiliar territory of a familiar drug: INH-induced erythroderma},
journal = {Eurasian Journal of Pulmonology},
year = {2022},
doi = {10.14744/ejp.2021.8321}
}
EUVIMED